High efficiency myogenic conversion of human fibroblasts by adenoviral vector-mediated MyoD gene transfer. An alternative strategy for ex vivo gene therapy of primary myopathies.

Ex vivo gene therapy of primary myopathies, based on autologous transplantation of genetically modified myogenic cells, is seriously limited by the number of primary myogenic cells that can be isolated, expanded, transduced, and reimplanted into the patient's muscles. We explored the possibilit...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Lattanzi, L, Salvatori, G, Coletta, M, Sonnino, C, Cusella De Angelis, M G, Gioglio, L, Murry, C E, Kelly, R, Ferrari, G, Molinaro, M, Crescenzi, M, Mavilio, F, Cossu, G
Médium: Artigo
Jazyk:Inglês
Vydáno: 1998
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC508800/
https://ncbi.nlm.nih.gov/pubmed/9593768
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky